Address
Cylene Pharmaceuticals Inc
5820 Nancy Ridge Drive Suite 200
San Diego, CA 92121
United States
Cylene Pharmaceuticals Inc
5820 Nancy Ridge Drive Suite 200
San Diego, CA 92121
United States
Cylene Pharmaceuticals Inc
5820 Nancy Ridge Drive, Suite 200
San Diego, CA 92121
United States
Cylene Pharmaceuticals Inc
5820 Nancy Ridge Drive, Suite 200
San Diego, CA 92121
United States
Cylene Pharmaceuticals Inc
5820 Nancy Ridge Drive, Suite 200
San Diego, CA 92121
United States
Website
VCID: 141774
Profile
Corporate information
Official name
Cylene Pharmaceuticals Incorporated
Registration country
Official name
Cylene Pharmaceuticals Incorporated
Registration country
Investment activity status
Active investor
Company type
Clinical stage private company developing small molecule drugs against newly validated cancer targets.Funding
Funding rounds
(1 Sep 2010)
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
BioVentures Investors LLC | United States | ||
|
HBM BioVentures AG | Switzerland | ||
|
Lilly Ventures | United States | ||
|
Mitsui & Co Global Investment Inc | United States | ||
|
Morningside Group | China | ||
|
Novartis Venture Funds | The corporate venturing arm of Novartis. | Switzerland |
(1 Jan 2007)
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
RCT BioVentures | The vehicle through which Research Corporation Technologies invests in start-up or early-stage companies | United States | Initial investment. Round participant. |
|
|
BioVentures Investors LLC | United States | ||
|
Celgene Corp | Biopharmaceutical company committed to improving the lives of patients worldwide. | United States | |
|
|
HBM BioVentures AG | Switzerland | ||
|
|
Lilly Ventures | United States | ||
|
|
Mitsui & Co Global Investment Inc | United States | ||
|
|
Novartis Venture Funds | The corporate venturing arm of Novartis. | Switzerland | |
|
Sanderling Ventures | United States |
(1 May 2005)
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
|
BioVentures Investors LLC | United States | ||
|
|
Coastview Capital LLC | United States | ||
|
|
Mitsui & Co Global Investment Ltd | Japan | ||
|
|
Morningside Group | China |
(31 Dec 2001)
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
|
RCT BioVentures | The vehicle through which Research Corporation Technologies invests in start-up or early-stage companies | United States | Initial investment. Round participant. |
|
IngleWood Ventures | United States |
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
|
RCT BioVentures | The vehicle through which Research Corporation Technologies invests in start-up or early-stage companies | United States |
Cap Table
Current and past shareholders
| Investor | Contacts | Round | |
|---|---|---|---|
|
|
BioVentures Investors LLC |
+1 (617) 252-3443 |
Series B Series C Series D |
|
|
Celgene Corp Biopharmaceutical company committed to improving the lives of patients worldwide. |
Series C | |
|
|
Coastview Capital LLC |
Series B | |
|
|
HBM BioVentures AG |
+41 (41) 768-1108 |
Series C Series D |
|
|
IngleWood Ventures |
+1 (858) 792-3579 |
Series A |
|
|
Lilly Ventures |
+1 (317) 651-3050 |
Series C Series D |
|
|
Mitsui & Co Global Investment Inc |
Series C Series D |
|
|
|
Mitsui & Co Global Investment Ltd |
+86 (21) 5298-5959 |
Series B |
|
|
Morningside Group |
+852 2894-9800 |
Series B Series D |
|
Novartis Services Inc |
+1 (617) 871-3536 |
N/A |
|
|
Novartis Venture Funds The corporate venturing arm of Novartis. |
+41 (61) 324-6210 |
Series C Series D |
|
|
RCT BioVentures The vehicle through which Research Corporation Technologies invests in start-up or early-stage companies |
+1 (310) 824-1700 |
N/A Series A Series C |
|
|
Sanderling Ventures |
+1 (650) 401-2000 |
Series C |